Delivery Order SPE2DB20D1109-SPE2DB25FP63B
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 on July 21, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by August 11, 2025, with performance taking place at the company's Conshohocken facility. The contract was funded by the Defense Logistics Agency's Medical Supply Chain division to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of September 4, 2025. The contract calls for delivery of Tezspire 210 mg/1.91 ml pen injectors, a specialty pharmaceutical product for respiratory conditions. This is a firm fixed-price, competitively awarded delivery order with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency on August 5, 2025, for TEZSPIRE 210 MG/1.91 ML pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 26, 2025, with performance taking place at the contractor's Conshohocken facility. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $35,153.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of September 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $9,374.36 on August 18, 2025, with completion scheduled for September 9, 2025. The contract covers the supply of Tezspire 210 mg/1.91 mL pen auto-injectors and was funded through the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order represents a non-set-aside award, indicating open...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,343.59 on August 18, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectables. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,343.59 firm fixed price delivery order on August 25, 2025, for Tezspire 210 mg/1.91 mL pen medication with a completion date of September 16, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger federal contract portfolio with DLA. The delivery order is to be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, valued at $2,343.59 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026. The award carries no set-aside designation and was competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 ml pen injectors, valued at $2,343.59, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The contract is performed from the company's corporate...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP63BDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency on August 22, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 15, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award involves no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement. This delivery order represents a child contract under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order for Tezspire, a specialty biologic injection used in asthma treatment, exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor to federal healthcare systems. As a major pharmaceutical and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, AmerisourceBergen maintains an extensive portfolio of federal medical contracts supplying brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide. The company's DLA Troop Support Medical prime vendor contract serves Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning it as a key vendor in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/22/25 |